90 related articles for article (PubMed ID: 20091685)
1. Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer.
Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Chiang ML; Chen HM; Kuo MY; Chiang CP
Head Neck; 2010 Oct; 32(10):1363-9. PubMed ID: 20091685
[TBL] [Abstract][Full Text] [Related]
2. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
3. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
[TBL] [Abstract][Full Text] [Related]
5. Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Chang HH; Kuo MY; Cheng SJ; Chiang CP
Oral Oncol; 2009 Jul; 45(7):589-93. PubMed ID: 18952491
[TBL] [Abstract][Full Text] [Related]
6. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
[TBL] [Abstract][Full Text] [Related]
7. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
8. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
10. Significant association of SRC protein expression with the progression, recurrence, and prognosis of oral squamous cell carcinoma in Taiwan.
Cheng SJ; Kok SH; Lee JJ; Yen-Ping Kuo M; Cheng SL; Huang YL; Chen HM; Chang HH; Chiang CP
Head Neck; 2012 Sep; 34(9):1340-5. PubMed ID: 22052839
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of vascular endothelial growth factor mRNA level is significantly related to progression and prognosis of oral squamous cell carcinomas.
Ko HH; Lee JJ; Chen HM; Kok SH; Yen-Ping Kuo M; Cheng SJ; Chiang CP
J Formos Med Assoc; 2015 Jul; 114(7):605-11. PubMed ID: 26058869
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
[TBL] [Abstract][Full Text] [Related]
13. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
14. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
[TBL] [Abstract][Full Text] [Related]
15. Infiltrating macrophage count: a significant predictor for the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lu CF; Huang CS; Tjiu JW; Chiang CP
Head Neck; 2010 Jan; 32(1):18-25. PubMed ID: 19484765
[TBL] [Abstract][Full Text] [Related]
16. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
[TBL] [Abstract][Full Text] [Related]
17. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
[TBL] [Abstract][Full Text] [Related]
18. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
19. Four-protein signature accurately predicts lymph node metastasis and survival in oral squamous cell carcinoma.
Zanaruddin SN; Saleh A; Yang YH; Hamid S; Mustafa WM; Khairul Bariah AA; Zain RB; Lau SH; Cheong SC
Hum Pathol; 2013 Mar; 44(3):417-26. PubMed ID: 23026198
[TBL] [Abstract][Full Text] [Related]
20. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity.
Züllig L; Roessle M; Weber C; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H; Huber GF
Eur J Cancer; 2013 May; 49(8):1915-22. PubMed ID: 23414798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
